U.S. News & World Report: Perlmutter Cancer Center Medical Oncologist Discusses Study on Blood Test for Early Cancer Detection

Patient Care, In the Media, Translational Medicine

September 12, 2022

Photo: Jasmin Merdan/Getty

Results of a preliminary study, reported at the 2022 European Society for Medical Oncology Congress, show that a single blood test can screen for more than 50 types of tumors.

Ruth Oratz, MD, a medical oncologist at ��ɫtv Langone Health’s Perlmutter Cancer Center, tells U.S. News & World Report that it would be “fantastic” to screen for many cancers with a single blood draw.

“This is very exciting technology,” says Dr. Oratz, also a clinical professor in the at ��ɫtv Grossman School of Medicine. “But, we’re not there yet.”

��ɫtv

Related Articles

Perlmutter Cancer Center Appoints Renowned Clinician–Scientist to Lead Its Transplantation & Cellular Therapy Center on Long Island

Dr. Anne S. Renteria will work to build out its blood cancer programs.

��ɫtv Langone Thoracic Surgeons Using Minimally Invasive Robotic Surgery to Shorten Hospital Stays & Improve Patient Outcomes for Lung Cancer

Such methods allow patients to go home 24 hours after their procedure.